Evidence map›Paper›PMID 33073606›Full record

ArticleCirculation2020

Comprehensive Metabolic Phenotyping Refines Cardiovascular Risk in Young Adults.

Venkatesh L Murthy, Jared P Reis, Alexander R Pico, Robert Kitchen, Joao A C Lima, Donald Lloyd-Jones, Norrina B Allen, Mercedes Carnethon, Gregory D Lewis, Matthew Nayor and 4 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Circulation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 2 syntheses or guidelines pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Multi-Omics Identification of Biomarkers for High-Altitude Pulmonary Hypertension.Journal of cardiovascular development and disease · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Metabolomic Pathways of Inflammation and Mitochondrial Dysfunction Are Related to Worsening Healthy Aging Index and Mortality.The journals of gerontology. Series A, Biological sciences and medical sciences · 2025
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 9 institutions in 2 countries.

Venkatesh L Murthy *Departments of Medicine and Radiology, University of Michigan, Ann Arbor (V.L.M.).
Jared P ReisNational Heart, Lung, and Blood Institute, Bethesda, MD (J.P.R.).
Alexander R PicoInstitute of Data Science and Biotechnology, Gladstone Institutes, University of California at San Francisco (A.R.P.).
Robert KitchenCardiology Division, Department of Medicine, Massachusetts General Hospital, Boston (R.K., G.D.L., M.N., R.V.S.).
Joao A C LimaCardiology Division, Department of Medicine, Johns Hopkins Hospital, Baltimore, MD (J.A.C.L.).
Donald Lloyd-JonesNorthwestern University, Chicago, IL (D.L.-J., N.B.A., M.C.).
Norrina B AllenNorthwestern University, Chicago, IL (D.L.-J., N.B.A., M.C.).
Mercedes CarnethonNorthwestern University, Chicago, IL (D.L.-J., N.B.A., M.C.).
Gregory D LewisCardiology Division, Department of Medicine, Massachusetts General Hospital, Boston (R.K., G.D.L., M.N., R.V.S.).
Matthew NayorCardiology Division, Department of Medicine, Massachusetts General Hospital, Boston (R.K., G.D.L., M.N., R.V.S.).
Ramachandran S VasanSections of Preventive Medicine and Epidemiology and Cardiovascular Medicine and Departments of Medicine and Epidemiology, Boston University Schools of Medicine and Public Health, MA (R.S.V.).
Jane E FreedmanDepartment of Medicine, University of Massachusetts Medical School, Worcester (J.E.F.).
Clary B ClishBroad Institute of Harvard and MIT, Cambridge, MA (C.B.C.).
Ravi V Shah *Cardiology Division, Department of Medicine, Massachusetts General Hospital, Boston (R.K., G.D.L., M.N., R.V.S.).
Massachusetts General Hospital · USNorthwestern University · USBroad Institute · USFramingham Heart Study · USGladstone Institutes · USJohns Hopkins Hospital · USNational Heart Lung and Blood Institute · USUniversity of Massachusetts Chan Medical School · USUniversity of Michigan · US

Funding

ROLE OF DIETARY CONSTITUENTS ON GENE EXPRESSION IN INTESTINAL EPITHELIUMP30DK040561 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Elizabeth Austen Lawson, Takara Leah Stanley · 1994 to 2026
$31.6M
FRAMINGHAM HEART STUDY - YEAR 5 EXAM75N92019D00031 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · 2019 to 2024
$29.8M
Metabolomic predictors of insulin resistance and diabetesR01DK081572 · NIDDK · VANDERBILT UNIVERSITY · PI CLISH, CLARY B, GERSZTEN, ROBERT E · 2008 to 2025
$9.3M
Implications of metabolism on healthy aging in African and Caucasian Americans: the Health ABC studyR01AG059729 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MURTHY, VENKATESH LOCHARLA, NEWMAN, ANNE B. · 2018 to 2022
$3.1M
Molecular markers of early cardiometabolic health transitions in the CARDIA studyR01HL136685 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MURTHY, VENKATESH LOCHARLA, SHAH, RAVI · 2017 to 2021
$2.6M
Metabolic Signatures of Impaired Cardiorespiratory Fitness: Correlates, Prognostic Significance and Modulation with Exercise TrainingK23HL138260 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI NAYOR, MATTHEW G. · 2017 to 2021
$998k
THE FRAMINGHAM HEART STUDY-N01HC25195-268025195-268025195N01HC025195 · HC · TRUSTEES OF BOSTON UNIVERSITY · PI WOLF, PHILIP A · 2002 to 2006
–
NHLBI NIH HHS 75N92019D00031NHLBI NIH HHS HHSN268201500001CNHLBI NIH HHS HHSN268201500001INHLBI NIH HHS HHSN268201800003INHLBI NIH HHS HHSN268201800004INHLBI NIH HHS HHSN268201800005INHLBI NIH HHS HHSN268201800006INHLBI NIH HHS HHSN268201800007INHLBI NIH HHS K23 HL138260NHLBI NIH HHS N01 HC025195NHLBI NIH HHS R01 HL136685NIA NIH HHS R01 AG059729NIDDK NIH HHS P30 DK040561NIDDK NIH HHS R01 DK081572
6 · The paper itself

Abstract

backgroundWhereas cardiovascular disease (CVD) metrics define risk in individuals >40 years of age, the earliest lesions of CVD appear well before this age. Despite the role of metabolism in CVD antecedents, studies in younger, biracial populations to define precise metabolic risk phenotypes are lacking.

methodsWe studied 2330 White and Black young adults (mean age, 32 years; 45% Black) in the CARDIA study (Coronary Artery Risk Development in Young Adults) to identify metabolite profiles associated with an adverse CVD phenome (myocardial structure/function, fitness, vascular calcification), mechanisms, and outcomes over 2 decades. Statistical learning methods (elastic nets/principal components analysis) and Cox regression generated parsimonious, metabolite-based risk scores validated in >1800 individuals in the Framingham Heart Study.

resultsIn the CARDIA study, metabolite profiles quantified in early adulthood were associated with subclinical CVD development over 20 years, specifying known and novel pathways of CVD (eg, transcriptional regulation, brain-derived neurotrophic factor, nitric oxide, renin-angiotensin). We found 2 multiparametric, metabolite-based scores linked independently to vascular and myocardial health, with metabolites included in each score specifying microbial metabolism, hepatic steatosis, oxidative stress, nitric oxide modulation, and collagen metabolism. The metabolite-based vascular scores were lower in men, and myocardial scores were lower in Black participants. Over a nearly 25-year median follow-up in CARDIA, the metabolite-based vascular score (hazard ratio, 0.68 per SD [95% CI, 0.50-0.92];

conclusionsMetabolic signatures of myocardial and vascular health in young adulthood specify known/novel pathways of metabolic dysfunction relevant to CVD, associated with outcome in 2 independent cohorts. Efforts to include precision measures of metabolic health in risk stratification to interrupt CVD at its earliest stage are warranted.

Indexed as

PhenotypeAdolescentAdultAgedCardiovascular DiseasesCohort StudiesFemaleHumansMaleMetabolomeMetabolomicsMiddle AgedProspective StudiesRisk FactorsYoung Adultaginglipidomicsmetabolomicsprevention and controlrisk

Identifiers

PMID33073606
PMCPMC7880553
OpenAlexW3092832796

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.